Elevance Health — Oct 21, 2025 release

As of September 30, 2025, cash and investments at the parent company totaled approximately $2.6 billion. During the third quarter of 2025, the Company repurchased 2.9 million shares of its common stock for $875 million, at a weighted average price of $303.48, and paid a quarterly dividend of $1.71 per share, representing a distribution of cash totaling $381 million. As of September 30, 2025, the Company had approximately $7.2 billion of Board approved share repurchase authorization remaining.   2      Health Benefits is comprised of Individual, Employer Group risk-based, Employer Group fee-based, BlueCard ® , Medicare, Medicaid, and Federal Employee Program businesses.       Health Benefits Reportable Segment Highlights (Unaudited)           (In billions)   Three Months Ended                           September 30,  2025      September 30,  2024             Operating Revenue 1     $42.2        $38.3        Operating Gain 1,2     $0.6        $1.6        Adjusted Operating Gain 1,3     $0.6        $1.6            Operating Margin 1     1.4%       4.2%       Adjusted Operating Margin 1     1.4%       4.2%             1. See “Basis of Presentation” on page 5 herein.   2.